Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
Ajani, Jaffer El Hajbi, Farid Cunningham, David Alsina, Maria Thuss-Patience, Peter Scagliotti, Giorgio V Van den Eynde, Marc[UCL] Kim, Sung-Bae Kato, Ken Shen, Lin Li, Liyun Ding, Ningning Shi, Jingwen Barnes, Gisoo Van Cutsem, Eric (2024) ESMO open — Vol. 9, no.1, p. 102202 [1-9] (2024)
- Journal article
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
Mehra, Niven Fizazi, Karim de Bono, Johann S Barthélémy, Philippe Dorff, Tanya Stirling, Adam Machiels, Jean-Pascal[UCL] Bimbatti, Davide Kilari, Deepak Dumez, Herlinde Buttigliero, Consuelo van Oort, Inge M Castro, Elena Chen, Hsiang-Chun Di Santo, Nicola DeAnnuntis, Liza Healy, Cynthia G Scagliotti, Giorgio V (2022) The oncologist — Vol. 27, no. 10, p. e783-e795 (2022)